CVS Health Co. (NYSE:CVS) Shares Purchased by Insight Folios Inc

Insight Folios Inc grew its stake in shares of CVS Health Co. (NYSE:CVS) by 3.5% during the third quarter, Holdings Channel reports. The firm owned 8,250 shares of the pharmacy operator’s stock after purchasing an additional 282 shares during the period. Insight Folios Inc’s holdings in CVS Health were worth $519,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of CVS. Deerfield Management Company L.P. Series C acquired a new position in CVS Health in the second quarter valued at $57,584,000. CX Institutional boosted its position in shares of CVS Health by 698.0% in the 3rd quarter. CX Institutional now owns 74,609 shares of the pharmacy operator’s stock valued at $4,691,000 after purchasing an additional 65,259 shares during the period. Cullinan Associates Inc. grew its stake in CVS Health by 43.8% during the 3rd quarter. Cullinan Associates Inc. now owns 122,682 shares of the pharmacy operator’s stock worth $7,125,000 after buying an additional 37,395 shares during the last quarter. Susquehanna Fundamental Investments LLC boosted its stake in CVS Health by 27.9% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 665,451 shares of the pharmacy operator’s stock worth $39,302,000 after purchasing an additional 145,158 shares during the period. Finally, First Hawaiian Bank increased its position in CVS Health by 30.1% in the 2nd quarter. First Hawaiian Bank now owns 100,302 shares of the pharmacy operator’s stock valued at $5,924,000 after acquiring an additional 23,213 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.7 %

Shares of NYSE CVS opened at $56.49 on Monday. The stock has a market cap of $70.92 billion, a PE ratio of 9.93, a PEG ratio of 0.84 and a beta of 0.54. The business has a fifty day moving average of $59.82 and a two-hundred day moving average of $59.84. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.66 and a current ratio of 0.86. CVS Health Co. has a 52-week low of $52.77 and a 52-week high of $83.25.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.73 by $0.10. The business had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.21 earnings per share. As a group, equities research analysts expect that CVS Health Co. will post 6.41 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be paid a $0.665 dividend. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.71%. CVS Health’s payout ratio is 46.75%.

Analysts Set New Price Targets

CVS has been the topic of a number of recent analyst reports. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Wells Fargo & Company lifted their price objective on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Mizuho reduced their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a report on Tuesday, October 1st. Finally, Truist Financial boosted their target price on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a report on Friday, October 11th. Nine analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $74.58.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.